(Q33357643)

English

Discovery and optimization of a novel series of N-arylamide oxadiazoles as potent, highly selective and orally bioavailable cannabinoid receptor 2 (CB2) agonists

scientific article

Statements

Discovery and optimization of a novel series of N-arylamide oxadiazoles as potent, highly selective and orally bioavailable cannabinoid receptor 2 (CB2) agonists (English)
0 references
0 references
0 references
0 references
Jean-Christophe Harmange
Stephen A Hitchcock

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit